Protalix Biotherapeutics Inc (PLX) Live Share Price, Invest From India

Protalix Biotherapeutics Inc Stock Performance

as on May 8, 2026 at 6:59 am IST

Day's Low
Day's High
$1.88
Day's Price Range
$2.03
$1.99
5.53%
Downside
2.01%
Upside
52 Week's Low
52 Week's High
$1.32
52-Week Price Range
$3.19
$1.99
33.67%
Downside
60.30%
Upside

Protalix Biotherapeutics Inc share price movements today

Previous Close: $2.02
Open: $2.02
Volume: 2.2M
Day's Low - High: $1.88 - $2.03
52 Week Low - High: $1.32 - $3.19

Protalix Biotherapeutics Inc Historical Returns

1 Month Return: -7.76 %
3 Month Return: -30.1 %
1 Year Return: -28.87 %
3 Year Return: -38.23 %
5 Year Return: 0 %

Protalix Biotherapeutics Inc Stock Fundamentals & Key Indicators

Check Protalix Biotherapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$162.8M

EPS (TTM)

0.215

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

-0.01%

PE Ratio (TTM)

PEG Ratio

-0.1

EBITDA

-4.0M

Revenue (TTM)

52.7M

Profit Margin

-12.52%

Return On Equity TTM

-14.44%

Protalix Biotherapeutics Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Protalix Biotherapeutics Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Protalix Biotherapeutics Inc	BUY	$162.8M	NA	NA	-12.52%
Alnylam Pharmaceuticals Inc	BUY	$40.5B	130.77%	76.32	12.55%
BeiGene, Ltd.	NA	$32.5B	NA	70.89	5.37%
Vertex Pharmaceuticals Inc	BUY	$108.5B	98.9%	25.38	35.51%
Regeneron Pharmaceuticals Inc	BUY	$75.6B	45.15%	17.6	29.65%

Stock Returns calculator for Protalix Biotherapeutics Inc Stock including INR - Dollar returns

The Protalix Biotherapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

Protalix Biotherapeutics Inc investment value today

Current value as on today

₹77,943

Returns

-₹22,057

(-22.06%)

Returns from Protalix Biotherapeutics Inc Stock

-₹29,930 (-29.93%)

Dollar Impact

₹7,872 (+7.87%)

Analyst Recommendation on Protalix Biotherapeutics Inc Stock

Based on 5 analysts

BUY

80.00%

Buy

20.00%

Hold

0.00%

Sell

Based on 5 analysts, 80% of analysts recommend a 'BUY' rating for Protalix Biotherapeutics Inc. Average target price of $11

Protalix Biotherapeutics Inc Share Price Target

Get share price movements and forecasts by analysts on Protalix Biotherapeutics Inc.

What analysts predicted

81.91%UPSIDE

Target Price

$11

Current Price

$1.99

Analyzed by

5 Analysts

Target

$11.00

Protalix Biotherapeutics Inc target price $11, a slight upside of 81.91% compared to current price of $1.99. According to 5 analysts rating.

Indian Investors' Interest in Protalix Biotherapeutics Inc Stock

Search interest for Protalix Biotherapeutics Inc Stock has decreased by -58% in the last 30 days, reflecting a downward trend in search activity.

Time period: April 8, 2026 to May 8, 2026

Change:-58% versus previous 30 day period

Protalix Biotherapeutics Inc Quarterly Profit & Loss

All numbers in Millions USD

	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Total Revenue	10	10	3	13	17	18	10	15	17	9
Gross Profit	5	1	1	4	9	14	1	9	9	4
Operating Income	-1	-5	-4	-2	3	7	-4	1	2	-4
EBITDA	0	-5	-4	-1	4	7	-3	1	2	-5
Interest Expense	0	0	0	0	0	0	0	0	0	0
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-1	-6	-4	-2	3	7	-3	0	2	-4
Income Tax Expense	0	0	0	0	0	0	0	0	0	0
Net Income	-1	-6	-4	-2	3	6	-3	0	2	-5
Net Profit Margin	-17.90%	-57.64%	-122.60%	-16.35%	18.02%	35.65%	-35.79%	1.05%	13.19%	-60.34%

Protalix Biotherapeutics Inc Annual Profit & Loss

All numbers in Millions USD

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	9	21	34	54	62	38	47	65	53	52
Gross Profit	0	5	24	43	52	22	28	42	29	25
Operating Income	-33	-34	-19	-10	2	-20	-13	10	3	-5
EBITDA	-23	-71	-17	-8	4	-18	-10	12	6	-4
Interest Expense	4	9	7	7	9	7	2	3	1	1
Depreciation	-	1	1	1	1	1	1	1	1	1
Income Before Tax	-29	-83	-26	-18	-6	-27	-14	8	4	-5
Income Tax Expense	10	7	0	7	8	6	0	0	1	0
Net Income	-29	-83	-26	-18	-6	-27	-14	8	2	-6
Net Profit Margin	-319.22%	-395.86%	-77.27%	-33.42%	-10.37%	-71.92%	-31.33%	12.69%	5.49%	-12.52%

Protalix Biotherapeutics Inc Quarterly Cash Flow

All numbers in Millions USD

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Net Income	-6	-4	-2	3	6	-3	0	2	1
Operating Cash Flow	3	4	-3	4	3	-5	-5	-3	2
Investing Cash Flow	0	0	0	20	-15	0	0	0	-1
Financing Cash Flow	-	-	-	-20	3	5	4	9	0
Change in Cash	3	3	-3	4	-7	0	-1	-4	1

Protalix Biotherapeutics Inc Annual Cash Flow

All numbers in Millions USD

	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Net Income	-85	-26	-18	-6	-27	-14	8	2	-6
Operating Cash Flow	-9	-7	-19	-26	-10	-25	-1	8	-11
Investing Cash Flow	-1	0	0	-19	18	-5	-16	4	-2
Financing Cash Flow	-1	-4	46	46	12	8	24	-16	9
Change in Cash	-12	-13	-20	0	20	-21	6	-3	-4

Insights on Protalix Biotherapeutics Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NO EFFECT
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 25.4% return, outperforming this stock by 63.6%
NO EFFECT
Against Peers
In the last 1 year, BeOne Medicines Ltd has given 34.9% return, outperforming this stock by 63.8%
NEGATIVE IMPACT
Price Dip
In the last 7 days, PLX stock has moved down by -6.0%
NEGATIVE IMPACT
Revenue Fall
Revenue is down for the last 2 quarters, 17.85M → 9.12M (in $), with an average decrease of 48.9% per quarter
NEGATIVE IMPACT
Profit Down
Netprofit is down for the last 2 quarters, 2.35M → -5.50M (in $), with an average decrease of 333.7% per quarter

About Protalix Biotherapeutics Inc

Protalix BioTherapeutics, Inc., a biopharmaceutical company, engages in the development, production, and commercialization of recombinant therapeutic proteins based on the ProCellEx plant cell-based protein expression system. The company provides Elelyso for the treatment of Gaucher disease; and Elfabrio for the treatment of adult patients with a confirmed diagnosis of Fabry disease. It is also developing PRX-115, a plant cell expressed recombinant PEGylated Uricase, which is in Phase 2 trial for the treatment of gout; and PRX-119, a plant cell expressed PEGylated recombinant human DNase I product candidate for the treatment of neutrophil extracellular traps diseases. The company has agreements and partnerships with Pfizer; Fundação Oswaldo Cruz; and Chiesi Farmaceutici S.p.A. Protalix BioTherapeutics, Inc. has strategic partnership with Secarna Pharmaceuticals GmbH & Co KG. The company is headquartered in Hackensack. New Jersey.

Organisation	Protalix Biotherapeutics Inc
Headquarters	2 University Plaza, Hackensack, NJ, United States, 07601
Industry	Biotechnology
CEO	Mr. Dror Bashan
E-voting on shares	Click here to vote

Key Management of Protalix Biotherapeutics Inc

Name	Title
Ms. Yael Fellous	Vice President of Human Resources
Mr. Dror Bashan	President, CEO & Director

FAQs

What is Protalix Biotherapeutics Inc share price today?

Protalix Biotherapeutics Inc share price today is $1.99 as on May 8, 2026 at 1:29 am IST at the close of the market. Protalix Biotherapeutics Inc share today touched a day high of $2.03 and a low of $1.88.

What is the 52 week high and 52 week low for Protalix Biotherapeutics Inc share?

Protalix Biotherapeutics Inc share touched a 52 week high of $3.19 on February 23, 2026 and a 52 week low of $1.32 on June 23, 2025. Protalix Biotherapeutics Inc stock price today i.e. May 8, 2026 at 1:29 am IST is closed at $1.99,which is 37.62% down from its 52 week high and 50.76% up from its 52 week low.

What is Protalix Biotherapeutics Inc's market capitalisation today?

Protalix Biotherapeutics Inc market capitalisation is $0.00T as on May 8, 2026 at 1:29 am IST.

How to invest in Protalix Biotherapeutics Inc Stock (PLX) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Protalix Biotherapeutics Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Protalix Biotherapeutics Inc Shares that will get you 0.7538 shares as per Protalix Biotherapeutics Inc share price of $1.99 per share as on May 8, 2026 at 1:29 am IST.

What is the minimum amount required to buy Protalix Biotherapeutics Inc Stock (PLX) from India?

Indian investors can start investing in Protalix Biotherapeutics Inc (PLX) shares with as little as ₹94.24 or $1 (as of May 8, 2026 at 4:44 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹942.40 in Protalix Biotherapeutics Inc stock (as per the Rupee-Dollar exchange rate as on May 8, 2026 at 4:44 am IST). Based on Protalix Biotherapeutics Inc share’s latest price of $1.99 as on May 8, 2026 at 1:29 am IST, you will get 5.0251 shares of Protalix Biotherapeutics Inc. Learn more about fractional shares .